相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ruthenium(III) complexes with imidazole ligands that modulate the aggregation of the amyloid-β peptide via hydrophobic interactions
Gideon K. Yawson et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2021)
Metal complexes that bind to the amyloid-β peptide of relevance to Alzheimer's disease
Luiza M. F. Gomes et al.
COORDINATION CHEMISTRY REVIEWS (2020)
NAMI-A preferentially reacts with the Sp1 protein: understanding the anti-metastasis effect of the drug
Siming Yuan et al.
CHEMICAL COMMUNICATIONS (2020)
NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
Enzo Alessio et al.
MOLECULES (2019)
Inhibition of Amyloid-β Aggregation by Cobalt(III) Schiff Base Complexes: A Computational and Experimental Approach
Aysenur Iscen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Modification of Aβ Peptide Aggregation via Covalent Binding of a Series of Ru(III) Complexes
Luiza M. F. Gomes et al.
FRONTIERS IN CHEMISTRY (2019)
Light-triggered dissociation of self-assembled beta-amyloid aggregates into small, nontoxic fragments by ruthenium (II) complex
Giyeong Son et al.
ACTA BIOMATERIALIA (2018)
Acetylcholinesterase and Aβ Aggregation Inhibition by Heterometallic Ruthenium(II)-Platinum(II) Polypyridyl Complexes
Nilima A. Vyas et al.
INORGANIC CHEMISTRY (2018)
Metals and Alzheimer's Disease: How Far Have We Come in the Clinic?
Paul A. Adlard et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
The Biology of Glial Cells and Their Complex Roles in Alzheimer's Disease: New Opportunities in Therapy
Saif Shahriar Rahman Nirzhor et al.
BIOMOLECULES (2018)
Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective
Enzo Alessio
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2017)
Role of Glutamate and NMDA Receptors in Alzheimer's Disease
Rui Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Mechanistic Insights into Tunable Metal-Mediated Hydrolysis of Amyloid-β Peptides
Jeffrey S. Derrick et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Photochemical Identification of Molecular Binding Sites on the Surface of Amyloid-β Fibrillar Aggregates
Amir Aliyan et al.
CHEM (2017)
Alzheimer's Disease and the Amyloid-β Peptide
M. Paul Murphy et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
Towards an understanding of amyloid-β oligomers: characterization, toxicity mechanisms, and inhibitors
Shin Jung C. Lee et al.
CHEMICAL SOCIETY REVIEWS (2017)
A Novel Tetradentate Ruthenium(II) Complex Containing Tris(2- pyridylmethyl)amine (tpa) as an Inhibitor of Beta-Amyloid Fibrillation
Sharon Chan et al.
Current Alzheimer Research (2016)
BDDCS, the Rule of 5 and drugability
Leslie Z. Benet et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
CF3 Derivatives of the Anticancer Ru(III) Complexes KP1019, NKP-1339, and Their Imidazole and Pyridine Analogues Show Enhanced Lipophilicity, Albumin Interactions, and Cytotoxicity
Stephanie W. Chang et al.
INORGANIC CHEMISTRY (2016)
X-ray Structure Analysis of Indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019) Bound to Human Serum Albumin Reveals Two Ruthenium Binding Sites and Provides Insights into the Drug Binding Mechanism
Aleksandar Bijelic et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Interpreting the Paramagnetic NMR Spectra of Potential Ru(III) Metallodrugs: Synergy between Experiment and Relativistic DFT Calculations
Jan Novotny et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in- human, open-label, dose-escalation phase I study with expansion cohort
Howard A. Burris et al.
ESMO OPEN (2016)
Albumin binding and ligand-exchange processes of the Ru( III) anticancer agent NAMI-A and its bis-DMSO analogue determined by ENDOR spectroscopy
Michael I. Webb et al.
DALTON TRANSACTIONS (2015)
Modulation of the Aβ peptide aggregation pathway by KP1019 limits Aβ-associated neurotoxicity
Michael R. Jones et al.
METALLOMICS (2015)
Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease
Sergio T. Ferreira et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Synthesis of 2-Pyridyl-benzimidazole Iridium(III), Ruthenium(II), and Platinum(II) Complexes. Study of the Activity as Inhibitors of Amyloid-β Aggregation and Neurotoxicity Evaluation
Gorakh S. Yellol et al.
INORGANIC CHEMISTRY (2015)
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
Suzanne Leijen et al.
INVESTIGATIONAL NEW DRUGS (2015)
Modulation of Amyloid-β Aggregation by Histidine-Coordinating Cobalt(III) Schiff Base Complexes
Marie C. Heffern et al.
CHEMBIOCHEM (2014)
Ruthenium(II) polypyridyl complex as inhibitor of acetylcholinesterase and Aβ aggregation
Nilima A. Vyas et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Chiral Metallohelical Complexes Enantioselectively Target Amyloid β for Treating Alzheimer's Disease
Meng Li et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
Robert Trondl et al.
CHEMICAL SCIENCE (2014)
Development of a Platinum Complex as an anti-Amyloid Agent for the Therapy of Alzheimer's Disease
Vijaya B. Kenche et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Structural insights into the interaction of platinum-based inhibitors with the Alzheimer's disease amyloid-β peptide
Victor A. Streltsov et al.
CHEMICAL COMMUNICATIONS (2013)
Increasing the Bioavailability of RuIII Anticancer Complexes through Hydrophobic Albumin Interactions
Michael I. Webb et al.
CHEMISTRY-A EUROPEAN JOURNAL (2013)
EPR as a probe of the intracellular speciation of ruthenium(III) anticancer compounds
Michael I. Webb et al.
METALLOMICS (2013)
Simultaneous Measurement of Amyloid Fibril Formation by Dynamic Light Scattering and Fluorescence Reveals Complex Aggregation Kinetics
Aaron M. Streets et al.
PLOS ONE (2013)
Promising in Vitro anti-Alzheimer Properties for a Ruthenium(III) Complex
Luigi Messori et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Facile Methodology for Monitoring Amyloid-β Fibrillization
Nathan P. Cook et al.
ACS CHEMICAL NEUROSCIENCE (2012)
NMR Solution Structure of Rat Aβ(1-16): Toward Understanding the Mechanism of Rats' Resistance to Alzheimer's Disease
Andrey N. Istrate et al.
BIOPHYSICAL JOURNAL (2012)
Metal ions and amyloid fiber formation in neurodegenerative diseases. Copper, zinc and iron in Alzheimer's, Parkinson's and prion diseases
John H. Viles
COORDINATION CHEMISTRY REVIEWS (2012)
Pyridine Analogues of the Antimetastatic Ru(III) Complex NAMI-A Targeting Non-Covalent Interactions with Albumin
Michael I. Webb et al.
INORGANIC CHEMISTRY (2012)
Influence of bromoethyl group on biological activity of 5-fluorouracil prodrug: Insights from X-ray crystallography and molecular docking
Xian-Chuan Li et al.
JOURNAL OF MOLECULAR STRUCTURE (2012)
Distinct cellular fates for KP1019 and NAMI-A determined by X-ray fluorescence imaging of single cells
Jade B. Aitken et al.
METALLOMICS (2012)
Biochemistry of Amyloid β-Protein and Amyloid Deposits in Alzheimer Disease
Colin L. Masters et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Identification of [PtCl2(phen)] Binding Modes in Amyloid-β Peptide and the Mechanism of Aggregation Inhibition
Guolin Ma et al.
CHEMISTRY-A EUROPEAN JOURNAL (2011)
Control of ligand-exchange processes and the oxidation state of the antimetastatic Ru(III) complex NAMI-A by interactions with human serum albumin
Michael I. Webb et al.
DALTON TRANSACTIONS (2011)
A phase I dose-escalation study of NKP-1339 in patients with advanced solid tumors refractory to treatment.
N. R. Dickson et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A DFT STUDY ON THE HYDROLYSIS MECHANISM OF THE NAMI-A-TYPE ANTITUMOR COMPLEX (HL)[trans-RUCl4L(dmso-S)](L=4-amino-1,2,4-triazole)
Lan Mei Chen et al.
JOURNAL OF THEORETICAL & COMPUTATIONAL CHEMISTRY (2011)
Group 9 metal-based inhibitors of beta-amyloid (1-40) fibrillation as potential therapeutic agents for Alzheimer's disease
Bradley Yat-Wah Man et al.
CHEMICAL SCIENCE (2011)
Inhibition of Aβ42 Peptide Aggregation by a Binuclear Ruthenium(II)-Platinum(II) Complex: Potential for Multimetal Organometallics as Anti-amyloid Agents
Amit Kumar et al.
ACS CHEMICAL NEUROSCIENCE (2010)
Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties
Travis T. Wager et al.
ACS CHEMICAL NEUROSCIENCE (2010)
fac-{Ru(Co)3}2+ Selectively Targets the Histidine Residues of the β-Amyloid Peptide 1-28. Implications for New Alzheimer's Disease Treatments Based on Ruthenium Complexes
Daniela Valensin et al.
INORGANIC CHEMISTRY (2010)
Preparation and characterization of toxic A beta aggregates for structural and functional studies in Alzheimer's disease research
Asad Jan et al.
NATURE PROTOCOLS (2010)
KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
Christian G. Hartinger et al.
CHEMISTRY & BIODIVERSITY (2008)
Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
C. -X. Gong et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Metals in Alzheimer's and Parkinson's diseases
Kevin J. Barnham et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2008)
Platinum-based inhibitors of amyloid-β as therapeutic agents for Alzheimer's disease
Kevin J. Barnham et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The rule of five revisited: Applying log D in place of log p in drug-likeness filters
Sanjivanjit K. Bhal et al.
MOLECULAR PHARMACEUTICS (2007)
Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole):: Aquation, redox properties, protein binding, and antiproliferative activity
Michael Groessl et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
The hydrolysis process of the anticancer complex [ImH][trans-RuCl4(Im)2]:: a theoretical study
Jincan Chen et al.
DALTON TRANSACTIONS (2007)
From bench to bedside -: preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)
Christian G. Hartinger et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
The heterocyclic ruthenium(III) complex KP1019 (FFC14A) causes DNA damage and oxidative stress in colorectal tumor cells
S Kapitza et al.
CANCER LETTERS (2005)
Metals and amyloid-β in Alzheimer's disease
CJ Maynard et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2005)
Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells
S Kapitza et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2005)
The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation
M Bacac et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2004)
Tuning of redox potentials for the design of ruthenium anticancer drugs -: An electrochemical study of [trans-RuCl4L(DMSO)]- and [trans-RuCl42]- complexes, where L = imidazole, 1,2,4-triazole, indazole
E Reisner et al.
INORGANIC CHEMISTRY (2004)
A phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent
JM Rademaker-Lakhai et al.
CLINICAL CANCER RESEARCH (2004)
An autocatalytic reaction, as a model for the kinetics of the aggregation of beta-amyloid
R Sabate et al.
BIOPOLYMERS (2003)
Photostability profiles of the experimental antimetastatic ruthenium complex NAMI-A
M Bouma et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2002)
A kinetic study of the chemical stability of the antimetastatic ruthenium complex NAMI-A
M Bouma et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
Prediction of pharmacokinetic properties using experimental approaches during early drug discovery
PR Chaturvedi et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2001)
Zinc binding to Alzheimer's Aβ(1-16) peptide results in stable soluble complex
SA Kozin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Hydrolysis of the tumor-inhibiting ruthenium[lll) complexes Hlm trans-[RnCl4(im)2] and Hlnd trans[RuCl4(ind)2] investigated by means of HPCE and HPLC-MS
A Küng et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2001)
EPR and electrochemistry of [NH4]trans-[RuCl4(DMSO)(L)] complexes (L = DMSO, py). X-ray molecular structure of [pyH][RuCl4(DMSO)(py)].
QA de Paula et al.
JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY (2000)
分享论文
